Haisco Pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001BC7
CNY
60.42
1.05 (1.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
1,092.92
882.98
957.74
1,050.59
922.02
742.34
953.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,092.92
882.98
957.74
1,050.59
922.02
742.34
953.14
Raw Material Cost
292.23
281.36
325.46
300.51
254.11
250.71
286.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.34
8.51
8.95
10.55
9.07
9.26
10.16
Selling and Distribution Expenses
499.54
398.37
494.49
465.78
409.69
346.56
387.05
Other Expenses
18.64
13.07
23.24
14.80
11.78
7.00
16.04
Total Expenditure (Excl Depreciation)
986.52
818.98
1,061.32
924.80
790.65
676.48
843.89
Operating Profit (PBDIT) excl Other Income
106.4
64
-103.6
125.8
131.4
65.9
109.2
Other Income
-1.16
14.61
133.42
164.97
35.70
80.53
42.78
Operating Profit (PBDIT)
170.90
143.45
65.78
359.05
175.11
206.41
192.71
Interest
8.34
8.51
8.95
10.55
9.07
9.26
10.16
Exceptional Items
0.13
-0.13
-0.03
0.09
-0.03
0.05
0.06
Gross Profit (PBDT)
800.68
601.62
632.28
750.08
667.90
491.63
666.84
Depreciation
65.42
65.42
66.30
66.30
61.04
61.04
51.09
Profit Before Tax
97.28
69.39
-9.51
282.28
104.97
136.16
131.51
Tax
7.30
11.83
-32.11
-5.69
29.09
5.47
12.21
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
82.21
46.61
13.64
217.10
72.76
91.96
94.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
82.21
46.61
13.64
217.10
72.76
91.96
94.37
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-0.01
0.55
71.90
-0.47
-1.24
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
82.21
46.60
14.19
289.00
72.29
90.72
94.37
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,064.66
4,115.93
4,213.33
4,192.22
4,136.10
4,296.52
4,179.89
Earnings per share (EPS)
0.07
0.04
0.01
0.19
0.07
0.08
0.08
Diluted Earnings per share
0.07
0.04
0.01
0.19
0.07
0.08
0.08
Operating Profit Margin (Excl OI)
9.76%
7.18%
-13.99%
12.16%
8.5%
8.73%
10.37%
Gross Profit Margin
14.89%
15.27%
5.93%
33.18%
18.01%
26.56%
19.16%
PAT Margin
7.52%
5.28%
1.42%
20.66%
7.89%
12.39%
9.9%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 18.54% vs 25.39% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 13.69% vs 67.36% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 23.46% vs 35.08% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is -8.79% vs -15.74% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Haisco Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,092.92
0
1,092.92
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,092.92
0
1,092.92
Raw Material Cost
292.23
0
292.23
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.34
0
8.34
Selling and Distribution Expenses
499.54
0
499.54
Other Expenses
18.64
0.00
18.64
Total Expenditure (Excl Depreciation)
986.52
0
986.52
Operating Profit (PBDIT) excl Other Income
106.40
0.00
106.40
Other Income
-1.16
0
-1.16
Operating Profit (PBDIT)
170.90
0
170.90
Interest
8.34
0
8.34
Exceptional Items
0.13
0
0.13
Gross Profit (PBDT)
800.68
0
800.68
Depreciation
65.42
0
65.42
Profit Before Tax
97.28
0
97.28
Tax
7.30
0
7.30
Provisions and contingencies
0
0
0.00
Profit After Tax
82.21
0
82.21
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
82.21
0
82.21
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
82.21
0
82.21
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,064.66
0
4,064.66
Earnings per share (EPS)
0.07
0
0.07
Diluted Earnings per share
0.07
0
0.07
Operating Profit Margin (Excl OI)
9.76%
0%
0.00
9.76%
Gross Profit Margin
14.89%
0%
0.00
14.89%
PAT Margin
7.52%
0%
0.00
7.52%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 109.29 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 23.77% vs -7.80% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 18.54% vs 25.39% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.22 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 76.39% vs 228.17% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 13.69% vs 67.36% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.21 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 33.62% vs 290.53% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 23.46% vs 35.08% in Jun 2024

Quarterly - Interest
Interest 0.83 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -2.35% vs -5.56% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -8.79% vs -15.74% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.76%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024